A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data

Autor: Rana K, Reid J, Rosenwasser JN, Lewis T, Sheikh-Ali M, Choksi RR, Goldfaden RF

Publikováno v: Diabetes, Metabolic Syndrome and Obesity, Vol Volume 12, Pp 1897-1911 (2019)

Khyatiben Rana,1 Jessica Reid,1 Joshua N Rosenwasser,2 Todd Lewis,3 Mae Sheikh-Ali,4 Rushab R Choksi,1 Rebecca F Goldfaden1 1East Coast Institute for Research, Jacksonville, FL, USA; 2Lincoln Medical and Mental Health Center, Bronx, NY, USA; 3Baker-G

Externí odkaz: https://doaj.org/article/a2387d7fe44e466b93a14ba37ad96e96

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data

Autor: Khyatiben, Rana, Jessica, Reid, Joshua N, Rosenwasser, Todd, Lewis, Mae, Sheikh-Ali, Rushab R, Choksi, Rebecca F, Goldfaden

Publikováno v: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Diabetes is a significant and independent risk factor for atherosclerotic cardiovascular disease (ASCVD), leading to morbidity and mortality among this population. The prevention of macrovascular complications, such as CVD, peripheral arterial diseas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::93802400281f3ad1909b29ce41cccb0f
https://pubmed.ncbi.nlm.nih.gov/31571964

RE: Praluent (Alirocumab)-Induced Renal Injury

Autor: Rosenson, Robert S, Larrey, Dominique, Waters, David D, Olsson, Anders G, Members of the Phase 3 Data Monitoring Committee for PRALUENT

Publikováno v: Rosenson, Robert S; Larrey, Dominique; Waters, David D; Olsson, Anders G; & Members of the Phase 3 Data Monitoring Committee for PRALUENT,. (2018). RE: Praluent (Alirocumab)-Induced Renal Injury.. Journal of pharmacy practice, 31(2), 138-139. doi: 10.1177/0897190017734429. UCSF: Retrieved from: http://www.escholarship.org/uc/item/5sv5h39c
Journal of pharmacy practice, vol 31, iss 2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::085ae282ac319bad893d2d819cbc80fc
http://www.escholarship.org/uc/item/5sv5h39c